Paul L Berns's Net Worth
Paul L Berns's net worth is estimated to be at least $1,083,160.37 as of 03/10/2026. CoreStreet's estimation of Paul L Berns's net worth is based on their sale of stock and current holding of stock.
Paul L Berns is Insider at Neumora Therapeutics, Inc. Common Stock. They have executed at least 4 trades of stock as per SEC Form 4 filings. Their most recent trade was for 9,819 units of NMRA stock on 02/17/2026. Their biggest sale was on 11/04/2020 when they sold 4,691 units of Jazz Pharmaceuticals PLC stock for $705,620.22. They typically trade 1 times per year.
Total value of insider buys:
- $248,826.52
Total value of insider sells:
- $834,333.85
Most recent insider trade:
- Feb. 17, 2026
Paul L Berns's Insider Trading History
| Neumora Therapeutics, Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 17, 2026 | Insider | 9,819 | $3.51 | Sell | $34,464.69 |
| Jazz Pharmaceuticals PLC | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 4, 2020 | Director | 4,691 | $150.42 | Sell | $705,620.22 |
Aug. 11, 2017 | Director | 662 | $142.37 | Sell | $94,248.94 |
| Cellectar Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 20, 2016 | Director | 117,371 | $2.12 | Buy | $248,826.52 |